ZURICH, Aug 3 (Reuters) - Privately owned Nycomed [NYCMD.UL] is to buy a portfolio of 20 branded generic products in a number of Central and Eastern European countries from French drugmaker Sanofi-Aventis (SASY.PA), the Swiss-based group said on Monday.
